Vaccines
26 July 2022
Bavarian Nordic Receives European Approval of Extension of Vaccine Label to Include Monkeypox29 June 2022
Icosavax Announces Positive Topline Interim Phase 1/1b Results for VLP Vaccine Candidate IVX-121 Against RSV25 June 2022
Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA200124 June 2022
Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine21 June 2022
Affinivax Presents Data for Enhanced Protection Against Serotype 3 in Next-Generation Pneumococcal Vaccine20 June 2022
Ultimovacs’ UV1 cancer vaccine shows strong overall survival in malignant melanoma phase I trial30 May 2022
RhoVac’s phase IIb study in prostate cancer , BRaVac, failed to meet its primary endpointNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports